Implementation of a Standardized Post-Cesarean Delivery Order Set with Multimodal Combination Analgesia Reduces Inpatient Opioid Usage

Eran Bornstein, Gregg Husk, Erez Lenchner, Amos Grunebaum, Therese Gadomski, Cristina Zottola, Sarah Werner, Jamie S Hirsch, Frank A Chervenak, Eran Bornstein, Gregg Husk, Erez Lenchner, Amos Grunebaum, Therese Gadomski, Cristina Zottola, Sarah Werner, Jamie S Hirsch, Frank A Chervenak

Abstract

Background: Opioid use has emerged as a leading cause of death in the US. Given that 1 in 300 opioid-naive patients exposed to opioids after cesarean birth will become persistent users, hospitals should strive to limit exposure to these medications. We set out to evaluate whether transitioning to a standardized order set based on multimodal combination analgesic therapy decreases the exposure to opioids after cesarean delivery. Methods: Our health system's post-cesarean pain management electronic medical record (EMR) order set was changed from standing NSAIDs (Ibuprofen 600 mg every 6 h) and additional acetaminophen and opioid medications (Oxycodone 5 mg/acetaminophen 325 mg every 3 h or Oxycodone 10 mg/acetaminophen 650 mg every 6 h for moderate and severe pain, respectively) as needed (PRN) to a multimodal combination therapy with acetaminophen (975 mg every 6 h) and NSAIDs (Ibuprofen 600 mg every 6 h) as primary analgesics and opioids PRN (Oxycodone immediate release (IR) 5 mg every 3 h for moderate to severe pain). We performed a retrospective analysis across seven hospitals comparing inpatient opioid use, administration of other analgesics, and severe pain episodes (pain score ≥ 7) between the patients who were treated before and after implementation of the multimodal order set. Chi square and Student t-test were used for statistical analysis with significance determined as p < 0.05. Results: A total of 12,898 cesarean births were included (8696 prior and 4202 after implementation). The multimodal order set was associated with marked decrease in the incidence of post cesarean opioid use (45.4% vs. 67.5%; p < 0.0001), lower average opioid dose (26.7 mg vs. 36.6 mg of oxycodone; p < 0.0001), and increased dose of acetaminophen (8422 mg vs. 4563 mg; p < 0.0001), while severe pain scores were less frequent (46.3% vs. 56.6%, p < 0.0001). Conclusions: Multimodal analgesic therapy for post-cesarean pain management reduces inpatient opioid use while improving pain control. Incorporation of a multimodal order set as a default in the EMR facilitates effective and widespread implementation on a large scale. Obstetric units should consider standardizing post-cesarean pain management orders to include routine (not PRN) multimodal combination therapy with acetaminophen and NSAIDs as primary analgesics.

Keywords: multimodal analgesics; narcotics; opioid; opioid use; order set; post-cesarean pain control; post-partum pain control.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cesarean Delivery (C/D) Patients Exclusion and Assignment Criteria.
Figure 2
Figure 2
Opioid Exposure during Hospital Course after Cesarean Delivery.

References

    1. Nanji J.A., Guo N., Riley E.T., Faulkner B., Do C., Carvalho B. Evaluation of Opioid Use with Split Doses of Oral Opioids in a Postcesarean Delivery Analgesia Order Set. Obstet. Gynecol. 2019;1341:120–127. doi: 10.1097/AOG.0000000000003305.
    1. Centers for Disease Control and Prevention; Dec 19, 2018. [(accessed on 1 March 2020)]. Understanding the Epidemic. Available online: .
    1. Bateman B.T., Choudhry N.K. Limiting the Duration of Opioid Prescriptions: Balancing Excessive Prescribing and the Effective Treatment of Pain. JAMA Intern. Med. 2016;1765:583–584. doi: 10.1001/jamainternmed.2016.0544.
    1. FastStats . Births—Method of Delivery. Centers for Disease Control and Prevention; Atlanta, GA, USA: Jan 20, 2020.
    1. Badreldin N., Grobman W.A., Chang K.T., Yee L.M. Opioid prescribing patterns among postpartum women. Am. J. Obstet. Gynecol. 2018;2191:e1–e103. doi: 10.1016/j.ajog.2018.04.003.
    1. Smith A.M., Young P., Blosser C.C., Poole A.T. Multimodal Stepwise Approach to Reducing In-Hospital Opioid Use after Cesarean Delivery: A Quality Improvement Initiative. Obstet. Gynecol. 2019;1334:700–706. doi: 10.1097/AOG.0000000000003156.
    1. American College of Obstetricians and Gynecologists Postpartum Pain Management. ACOG Practice Bulletin, 742. [(accessed on 20 October 2020)];Obstet. Gynecol. 2019 132 Available online: .
    1. Sinatra R. Causes and Consequences of Inadequate Management of Acute Pain. Pain Med. 2010;11:1859–1871. doi: 10.1111/j.1526-4637.2010.00983.x.
    1. Practice Guidelines for Acute Pain Management in the Perioperative Setting: An Updated Report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;1162:248–273. doi: 10.1097/ALN.0b013e31823c1030.
    1. Linden A. Conducting Interrupted Time-series Analysis for Single- and Multiple-group Comparisons. Stata J. 2015;15:480–500. doi: 10.1177/1536867X1501500208.
    1. Bateman M.B.T., Franklin J.M., Bykov K., Avorn J., Shrank W.H., Brennan T.A., Landon J.E., Rathmell J.P., Huybrechts K.F., Fischer M.A., et al. Persistent opioid use following cesarean delivery: Patterns and predictors among opioid-naïve women. Am. J. Obstet. Gynecol. 2016;215:353.e1–353.e18. doi: 10.1016/j.ajog.2016.03.016.
    1. Khan M.I.A., Walsh D., Brito-Dellan N. Opioid and Adjuvant Analgesics: Compared and Contrasted. Am. J. Hosp. Palliat. Med. 2011;28:378–383. doi: 10.1177/1049909111410298.
    1. Valentine A., Carvalho B., Lazo T., Riley E. Scheduled acetaminophen with as-needed opioids compared to as-needed acetaminophen plus opioids for post-cesarean pain management. Int. J. Obstet. Anesth. 2015;24:210–216. doi: 10.1016/j.ijoa.2015.03.006.
    1. Rogers R.G., Nix M., Chipman Z., Breen M., Dieterichs C., Nutt S., Moxham J., Chang P., Rathouz P.J., Robertson H., et al. Decreasing Opioid Use Postpartum: A Quality Improvement Initiative. Obstet Gynecol. 2019;1345:932–940. doi: 10.1097/AOG.0000000000003512.
    1. Militsakh O., Lydiatt W., Lydiatt D., Interval E., Lindau R., Coughlin A., Panwar A. Development of Multimodal Analgesia Pathways in Outpatient Thyroid and Parathyroid Surgery and Association with Postoperative Opioid Prescription Patterns. JAMA Otolaryngol. Neck Surg. 2018;144:1023–1029. doi: 10.1001/jamaoto.2018.0987.
    1. Lucas J., Gross M., Yafi F., DeLay K., Christianson S., El-Khatib F.M., Osman M., Simhan J. A Multi-institutional Assessment of Multimodal Analgesia in Penile Implant Recipients Demonstrates Dramatic Reduction in Pain Scores and Narcotic Usage. J. Sex. Med. 2020;17:518–525. doi: 10.1016/j.jsxm.2019.11.267.
    1. Hajewski C.J., Westermann R.W., Holte A., Shamrock A., Bollier M., Wolf B.R. Impact of a Standardized Multimodal Analgesia Protocol on Opioid Prescriptions after Common Arthroscopic Procedures. Orthop. J. Sports Med. 2019;7 doi: 10.1177/2325967119870753.
    1. Cicero T.J., Ellis M.S., Surratt H.L., Kurtz S.P. The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 Years. JAMA Psychiatry. 2014;717:821–826. doi: 10.1001/jamapsychiatry.2014.366.
    1. Osmundson S.S., Schornack L.A., Grasch J.L., Zuckerwise L.C., Young J.L., Richardson M.G. Postdischarge Opioid Use after Cesarean Delivery. Obstet. Gynecol. 2017;130:36–41. doi: 10.1097/AOG.0000000000002095.
    1. Anderson S.B., Lin S.N., Reiss J., Skupski D., Grunebaum A. Peripartum thromboprophylaxis before and after implementation of a uniform heparin protocol. J. Perinat. Med. 2014;42:219–223. doi: 10.1515/jpm-2013-0165.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa